One of the HVC's portfolio company in US, Tacere Ttherapeutics, enters collaboration and license agreement with Pfizer to develop and commercialize RNAi Hepatitis C drug
- January 8, 2008
HVC Global Investment, Inc. (HVCGI), together with HVC, Inc., placed a founding capital by way of its venture capital fu...
